Changes in the commercial brand of tacrolimus lead to subtherapeutic trough levels and acute rejection in renal transplant recipients-Reference-Cited by-同舟云学术

Changes in the commercial brand of tacrolimus lead to subtherapeutic trough levels and acute rejection in renal transplant recipients

Published:2019-11-26 Issue:12 Volume:33 Page:
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Arreola‐Guerra José Manuel¹²^ORCID,Alberú Josefina³,Chew‐Wong Alfredo¹,Macias Dulce Maria⁴,Hernández‐Rosales Jesus⁵,Zuñiga‐Macías Leslie¹,Delgadillo‐Castañeda Rodolfo⁴,Ricalde‐Ríos Guadalupe¹,Haro‐Alcalde Fabian²,Villafán‐Bernal J. Rafael⁶,Ramos‐Medellín Carmen L.²,Reyes‐Acevedo Rafael⁴

Affiliation:

1. Department of Nephrology Centenario Hospital Miguel Hidalgo Aguascalientes Mexico

2. Department of Internal Medicine Centenario Hospital Miguel Hidalgo Aguascalientes Mexico

3. Tecnologico de Monterrey Escuela de Medicina y Ciencias de la Salud Monterrey Mexico

4. Department of Transplantation Centenario Hospital Miguel Hidalgo Aguascalientes Mexico

5. Department of Histocompatibility Laboratorios Clínicos del Campestre Aguascalientes Mexico

6. Health Science Center Autonomous University of Aguascalientes Aguascalientes Mexico

Publisher

Wiley

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.13749

Reference37 articles.

1. A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1

2. RANDOMIZED TRIAL OF TACROLIMUS (PROGRAF) IN COMBINATION WITH AZATHIOPRINE OR MYCHOPHENOLATE MOFETIL VERSUS CYCLOSPORINE (NEORAL) WITH MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION1, 2

3. Kidney transplantation: consecutive one thousand transplants at National Institute of Medical Sciences and Nutrition Salvador Zubirán in Mexico City;Marino‐Vazquez LA;Rev Invest Clin,2011

4. Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients